UB Paderborn / Katalog / Suche / in CDI

1 – 24 von 24

Sortiert nach

Hepatitis B virus reactivation and alemtuzumab therapy

European journal of haematology, 2005-03, Vol.74 (3), p.254-258

2005

Volltextzugriff (PDF)

Monoclonal antibodies: potential new therapeutic treatment against multiple myeloma

European journal of haematology, 2013-06, Vol.90 (6), p.441-468

2013

Volltextzugriff (PDF)

Splenic marginal zone lymphoma: a prognostic model for clinical use

Blood, 2006-06, Vol.107 (12), p.4643-4649

2006

Volltextzugriff (PDF)

Use of intrapleural bortezomib in myelomatous pleural effusion

British journal of haematology, 2007-11, Vol.139 (4), p.621-622

2007

Volltextzugriff (PDF)

Angioimmunoblastic T-cell lymphoma

Critical reviews in oncology/hematology, 2008-12, Vol.68 (3), p.264-271

2008

Volltextzugriff (PDF)

Splenic marginal zone lymphoma with or without villous lymphocytes: Hematologic findings and outcomes in a series of 57 patients

Cancer, 2004-11, Vol.101 (9), p.2050-2057

2004

Volltextzugriff (PDF)

Non-Pegylated Lyposomal Doxorubicin, Cyclophosphamide, Vincristine, Prednisone and Rituximab (R-COMP) as Initial Treatment for Patients with Splenic Marginal Zone Lymphoma (SMZL). A GISL Study

Blood, 2007-11, Vol.110 (11), p.1293-1293

2007

Volltextzugriff (PDF)

Deoxycoformycin (pentostatin) in the treatment of splenic marginal zone lymphoma (SMZL) with or without villous lymphocytes

European journal of haematology, 2005-08, Vol.75 (2), p.130-135

2005

Volltextzugriff (PDF)

Pre-Emptive Treatment with Cidofovir for Cytomegalovirus Antigenemia in Autologous Bone Marrow Recipient and CLL Patients on Therapy with Alemtuzumab

Blood, 2006-11, Vol.108 (11), p.5286-5286

2006

Volltextzugriff (PDF)

Response-Based Chemotherapy and Involved Field Radiation for Intermediate Stage Hodgkin Disease. A GISL/NHLSG Trial

Blood, 2006-11, Vol.108 (11), p.2475-2475

2006

Volltextzugriff (PDF)

Assessment of the frequency of additional cancers in patients with splenic marginal zone lymphoma

European journal of haematology, 2006-02, Vol.76 (2), p.134-140

2006

Volltextzugriff (PDF)

Hepatitis B Virus Reactivation and Alemtuzumab Therapy

Blood, 2004-11, Vol.104 (11), p.4816-4816

2004

Volltextzugriff (PDF)

Splenic marginal zone lymphoma with or without villous lymphocytes

Cancer, 2004-11, Vol.101 (9), p.2050-2057

2004

Volltextzugriff (PDF)

Assessment of the Frequency of Additional Malignancies in Patients with Splenic Marginal Zone Lymphoma (SMZL)

Blood, 2004-11, Vol.104 (11), p.4536-4536

2004

Volltextzugriff (PDF)

Deferment of objective assessment of deep vein thrombosis and pulmonary embolism without increased risk of thrombosis: a practical approach based on the pretest clinical model, D-dimer testing, and the use of low-molecular-weight heparins

Archives of internal medicine (1960), 2004-12, Vol.164 (22), p.2477

2004

Volltextzugriff (PDF)

Use of intrapleural bortezomib in myelomatous pleural effusion

British journal of haematology, 2007, Vol.139 (4), p.621-622

2007

Volltextzugriff (PDF)

Hepatitis B virus reactivation and alemtuzumab therapy

European Journal of Haematology, 2005, Vol.74 (3), p.254-258

2005

Volltextzugriff (PDF)

Monitoring cardiovascular diseases and associated risk factors in the adult population to better orient prevention strategies in Italy

Annali dell'Istituto superiore di sanità, 2022-01, Vol.58 (2), p.109

2022

Volltextzugriff (PDF)

Simultaneous quantification of 8-iso-prostaglandin-F2α and 11-dehydro thromboxane B2 in human urine by liquid chromatography–tandem mass spectrometry

Analytical biochemistry, 2010-02, Vol.397 (2), p.168-174

2010

Volltextzugriff (PDF)

Assessment of oxidative stress in coronary artery bypass surgery: comparison between the global index OXY-SCORE and individual biomarkers

Biomarkers, 2009-11, Vol.14 (7), p.465-472

2009

Volltextzugriff (PDF)

O81. NO synthesis impairment and homocysteine in acute coronary disease

Nitric oxide, 2008, Vol.19, p.39-39

2008

Volltextzugriff (PDF)

Assessment of oxidative stress in coronary artery bypass surgery: comparison between the global index OXY-SCORE and individual biomarkers

Biomarkers, 2009-07, p.90728060330030-8

2009

Volltextzugriff (PDF)

Simultaneous quantification of 8-iso-prostaglandin-F(2alpha) and 11-dehydro thromboxane B(2) in human urine by liquid chromatography-tandem mass spectrometry

Analytical biochemistry, 2010-02, Vol.397 (2), p.168-174

2010

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(22)
Berichte
(2)

Sprache

Englisch
(24)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Humans
(12)
Life Sciences & Biomedicine
(12)
Science & Technology
(12)
Male
(10)
Aged
(9)
Middle Aged
(9)
Female
(8)
Hematology
(7)
Adult
(5)
Biological And Medical Sciences
(5)
Medical Sciences
(5)
Aged, 80 And Over
(3)
Hematologic And Hematopoietic Diseases
(3)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(3)
Oncology
(3)
Splenic Lymphoma With Villous Lymphocytes
(3)
Splenic Marginal Zone Lymphoma
(3)
Splenic Neoplasms - Mortality
(3)
Survival Rate
(3)
Acute Hepatitis
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Hepatitis B virus reactivation and alemtuzumab therapy

Monoclonal antibodies: potential new therapeutic treatment against multiple myeloma

Splenic marginal zone lymphoma: a prognostic model for clinical use

Use of intrapleural bortezomib in myelomatous pleural effusion

Angioimmunoblastic T-cell lymphoma

Splenic marginal zone lymphoma with or without villous lymphocytes: Hematologic findings and outcomes in a series of 57 patients

Non-Pegylated Lyposomal Doxorubicin, Cyclophosphamide, Vincristine, Prednisone and Rituximab (R-COMP) as Initial Treatment for Patients with Splenic Marginal Zone Lymphoma (SMZL). A GISL Study

Deoxycoformycin (pentostatin) in the treatment of splenic marginal zone lymphoma (SMZL) with or without villous lymphocytes

Pre-Emptive Treatment with Cidofovir for Cytomegalovirus Antigenemia in Autologous Bone Marrow Recipient and CLL Patients on Therapy with Alemtuzumab

Response-Based Chemotherapy and Involved Field Radiation for Intermediate Stage Hodgkin Disease. A GISL/NHLSG Trial

Assessment of the frequency of additional cancers in patients with splenic marginal zone lymphoma

Hepatitis B Virus Reactivation and Alemtuzumab Therapy

Splenic marginal zone lymphoma with or without villous lymphocytes

Assessment of the Frequency of Additional Malignancies in Patients with Splenic Marginal Zone Lymphoma (SMZL)

Response-Guided ABVD Chemotherapy plus Involved-Field Radiation Therapy for Intermediate-Stage Hodgkin Lymphoma in the Pre–Positron Emission Tomography Era: A Gruppo Italiano Studio Linfomi (GISL) Prospective Trial

Deferment of objective assessment of deep vein thrombosis and pulmonary embolism without increased risk of thrombosis: a practical approach based on the pretest clinical model, D-dimer testing, and the use of low-molecular-weight heparins

Use of intrapleural bortezomib in myelomatous pleural effusion

Hepatitis B virus reactivation and alemtuzumab therapy

Monitoring cardiovascular diseases and associated risk factors in the adult population to better orient prevention strategies in Italy

Simultaneous quantification of 8-iso-prostaglandin-F2α and 11-dehydro thromboxane B2 in human urine by liquid chromatography–tandem mass spectrometry

Assessment of oxidative stress in coronary artery bypass surgery: comparison between the global index OXY-SCORE and individual biomarkers

O81. NO synthesis impairment and homocysteine in acute coronary disease

Assessment of oxidative stress in coronary artery bypass surgery: comparison between the global index OXY-SCORE and individual biomarkers

Simultaneous quantification of 8-iso-prostaglandin-F(2alpha) and 11-dehydro thromboxane B(2) in human urine by liquid chromatography-tandem mass spectrometry

Suchergebnisse filtern